Emmaus Life Sciences, Inc. financial data

Symbol
EMMA on OTC
Industry
Pharmaceutical Preparations
Location
21250 Hawthorne Boulevard, Suite 800, Torrance, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
MYnd Analytics, Inc. (to 7/12/2019), CNS RESPONSE, INC. (to 12/10/2015), STRATIVATION, INC. (to 3/1/2007), SalesTactix, Inc. (to 8/23/2005), AGE RESEARCH INC (to 8/5/2004)
Latest financial report
10-Q - Q2 2024 - Sep 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15.1 % +8.7%
Quick Ratio 2.62 % -38.4%
Debt-to-equity -171 % +25.9%
Return On Assets -15.2 % -38.8%
Operating Margin -3.9 % -1433%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.9M shares +19.1%
Common Stock, Shares, Outstanding 63.9M shares +19.1%
Entity Public Float 8.86M USD -43.2%
Common Stock, Value, Issued 64K USD +18.5%
Weighted Average Number of Shares Outstanding, Basic 63.4M shares +19.8%
Weighted Average Number of Shares Outstanding, Diluted 63.4M shares +19.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20M USD -29.6%
Cost of Revenue 903K USD -57.4%
Research and Development Expense 954K USD -39.2%
Selling and Marketing Expense 7.36M USD -17.6%
General and Administrative Expense 11.5M USD -26.4%
Operating Income (Loss) -779K USD -1039%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.31M USD -1.96%
Income Tax Expense (Benefit) -50K USD -1150%
Net Income (Loss) Attributable to Parent -5.26M USD -1.08%
Earnings Per Share, Basic -0.07 USD/shares +30%
Earnings Per Share, Diluted -0.07 USD/shares +30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.53M USD +12.1%
Accounts Receivable, after Allowance for Credit Loss, Current 4.6M USD -17.5%
Inventory, Net 1.63M USD -10.3%
Other Assets, Current 654K USD +50.7%
Assets, Current 9.01M USD -8.48%
Property, Plant and Equipment, Net 54K USD -20.6%
Operating Lease, Right-of-Use Asset 1.9M USD -26.4%
Other Assets, Noncurrent 308K USD +11.6%
Assets 25.9M USD -48.4%
Accounts Payable, Current 7.21M USD +110%
Employee-related Liabilities, Current 1.26M USD +15.1%
Accrued Liabilities, Current 8.16M USD -8.85%
Liabilities, Current 64M USD +4.03%
Operating Lease, Liability, Noncurrent 1.32M USD -40.6%
Other Liabilities, Noncurrent 15.4M USD -15.2%
Liabilities 83M USD -2.77%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.39M USD -2877%
Retained Earnings (Accumulated Deficit) -263M USD -2.05%
Stockholders' Equity Attributable to Parent -57M USD -62.7%
Liabilities and Equity 25.9M USD -48.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 140K USD
Net Cash Provided by (Used in) Financing Activities -955K USD -145%
Net Cash Provided by (Used in) Investing Activities -4K USD +99.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 63.9M shares +19.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -835K USD -238%
Interest Paid, Excluding Capitalized Interest, Operating Activities 873K USD +216%
Deferred Tax Assets, Valuation Allowance 42.9M USD -2.76%
Deferred Tax Assets, Gross 43.3M USD -2.73%
Operating Lease, Liability 2.23M USD -25.8%
Depreciation 26K USD -27.8%
Payments to Acquire Property, Plant, and Equipment 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.54M USD -332%
Lessee, Operating Lease, Liability, to be Paid 2.53M USD -30.1%
Property, Plant and Equipment, Gross 524K USD +1.75%
Operating Lease, Liability, Current 903K USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 846K USD -25.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.13M USD +2.82%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 307K USD -50.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 856K USD -21.6%
Deferred Tax Assets, Operating Loss Carryforwards 17.6M USD -2.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 836K USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 31K USD
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 6K USD -33.3%
Deferred Tax Assets, Net of Valuation Allowance 427K USD 0%
Interest Expense 6.96M USD +10.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%